controlled trial · 2024
“Compared with the control, Met (−60 min), Met (−30 min) and Met (0 min) all reduced the plasma glucose iAUC 0–120min ( p <0.01 for each), but the magnitude of this reduction was greater after Met (−60 min) and Met (−30 min) compared with Met (0 min) ( p =0.03 and p =0.001, respectively).”
Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study. Diabetologia
Who: 16 adults with type 2 diabetes on stable metformin monotherapy (14 men, 2 women; age 69.9±1.9 years; BMI 28.7; HbA1c 6.6%)
PMID 38561463